Cue Biopharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-12.1M | $-13.2M | $1.0M | $2.8M |
| FY2018 | $-26.4M | $-28.3M | $1.9M | $7.2M |
| FY2019 | $-30.8M | $-30.8M | $46.4K | $6.5M |
| FY2020 | $-32.5M | $-33.1M | $595.3K | $10.5M |
| FY2021 | $-38.8M | $-39.8M | $913.0K | $11.5M |
| FY2022 | $-41.8M | $-42.0M | $171.0K | $9.5M |
| FY2023 | $-40.0M | $-40.0M | $0 | $8.2M |
| FY2024 | $-36.3M | $-36.4M | $66.0K | $6.8M |
| FY2025 | $-21.7M | $-21.9M | $177.0K | $4.7M |